Skip to content

ZONIAPHARMA

Active
Private limited companyfounded 200916 yrs activeZoniënwoudlaan 54, 1640 Sint-Genesius-Rode, BelgiumKBO/BCE: BE 0821.624.939
Summary

ZONIAPHARMA has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €117,035 and a net result of €153,845. Equity remains stable across the filed fiscal years (±0.6% per year). Its solvency ranks better than 25% of 11293 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisWatch ReportCompare
ZONIAPHARMAActiveChecked score 86/100
Risk analysis ReportCompare

Overview

What they do
Retail sale of pharmaceutical products
NACE 47730
1 site
How big
€804,389total assets 2025
Staff
0.9 FTE
Equity
€117,035
Profit
€153,845
Turnover not published (abridged schema)
Financially healthy?
86 Excellent Checked score 2025
Bankruptcy chance 12 m
0.3%
Who decides
Parent
TOURNOV · 100%
Accounts 9 d early0 of 6 deeds read
Why 86- Equity €117,035 (14.5% of total assets)- Sector Retail trade (NACE 47)+ Founded in 2009+ Figures for FY 2025 (filed 22-07-2026)Show the evidence

Checked score

Score 2025
86 / 100
Excellent
Probability in this band: under 0.55%
Better than 50% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Average
Solvency 40+2
equity 14.5% of total assets
Liquidity 45-6
short-term debt 65.3% · cash 23.4%
Profitability 93+10
return on assets 19.1%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.7% (39,869 companies)
Last 24 months 11-2024: 0.6% 12-2024: 0.6%● 0.0% vs 11-2024 01-2025: 0.6%▼ -0.7% vs 12-2024 02-2025: 0.6%▲ +1.3% vs 01-2025 03-2025: 0.6%▼ -3.7% vs 02-2025 04-2025: 0.6%▼ -6.7% vs 03-2025 05-2025: 0.6%▲ +0.2% vs 04-2025 06-2025: 0.6%▲ +17.1% vs 05-2025 07-2025: 0.7%▲ +11.8% vs 06-2025highest value 08-2025: 0.4%▼ -40.2% vs 07-2025 09-2025: 0.4%● 0.0% vs 08-2025 10-2025: 0.4%● 0.0% vs 09-2025 11-2025: 0.4%● 0.0% vs 10-2025 12-2025: 0.4%● 0.0% vs 11-2025 01-2026: 0.4%▼ -0.7% vs 12-2025 02-2026: 0.5%▲ +6.3% vs 01-2026 03-2026: 0.5%▲ +2.0% vs 02-2026 04-2026: 0.4%▼ -3.8% vs 03-2026 05-2026: 0.5%▲ +2.2% vs 04-2026 06-2026: 0.5%▲ +8.3% vs 05-2026 07-2026: 0.5%▲ +10.2% vs 06-2026 08-2026: 0.3%▼ -47.2% vs 07-2026lowest value 09-2026: 0.3%● 0.0% vs 08-2026lowest value 10-2026: 0.3%● 0.0% vs 09-2026lowest value
  • Equity €117,035 (14.5% of total assets) raises the probability
  • Sector Retail trade (NACE 47) raises the probability
  • Founded in 2009 lowers the probability for this profile
  • Figures for FY 2025 (filed 22-07-2026) lowers the probability
Credit up to €10,000 at 30 days acceptable
Liquidity short (current ratio 0.99 against 0.98 in 2024; short-term debt: 65.3% and cash: 23.4% of total assets), and 85.5% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 30%, liquidity 43%, profitability 87%, growth against the median 39%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610020317, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Equity €117,035 (14.5% of total assets)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
lowers risk · Founded in 2009
In the bankruptcy model this factor lowers the probability for this profile.
KBO
lowers risk · Figures for FY 2025 (filed 22-07-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 25% of 11293 sector peers (2025).
NBB · sector comparison
Position among 11293 sector peers
Solvency
better than 25%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
9 d early
2024
9 d early
2023
29 d late
2022
31 d late
2021
31 d late
2020
25 d late
2019
21 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 17 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 August (5 of the last 5 filed years within 39 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · abbreviated…
  3. Weakest financial yearnet €99,889 ▼41.5%

Key points

  • Positive: Among the best 17% on net resultsector median €28,692 · 11,279 companies €153,845 View
  • Positive: Result rose in 2025from €99,889 to €153,845 ▲ 54.0% View
  • Positive: 8 profitable years in a rowprofit 2025: €153,845 8 years View
  • Controlled by TOURNOV 100% View

By topic

Financials

Fiscal year
2025
Total assets
€804,389
Profit
€153,845
Solvency
14.5%
Total assets▼ 9.3%
Net result
20182025
Go to Financials

Timeline

Events
13
Since
2017
Next accounts
by 31-07-2027
  1. 22-07-2026Annual accounts filed
  2. 22-07-2025Annual accounts filed
  3. 31-12-2024Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
21-12-2009
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure